Ticker brief
DNTH
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
5
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-29 → 2026-06-30 · now +0.40 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @CrweWorld | C | · | 1 | +0.30 |
| @OpenOutcrier | C | · | 1 | +0.25 |
| @OzmosiHealth | C | · | 1 | +0.30 |
| @USAnt_IDEA | C | -0.65 | 1 | +0.25 |
| @fundmyfund | B | -2.01 | 1 | +0.40 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-30 | @fundmyfund | +0.40 | DNTH consolidated after a large move and could be ready for a new leg. | · | tweet ↗ |
| 2026-06-29 | @USAnt_IDEA | +0.25 | Korean biotech pipeline roundup cites FDA approvals, trial starts, and results. | · | tweet ↗ |
| 2026-06-29 | @OzmosiHealth | +0.30 | Dianthus announces initiation of Phase 3 Emerge trial. | · | tweet ↗ |
| 2026-06-29 | @OpenOutcrier | +0.25 | Dianthus launched a Phase 3 study in rare muscle disease. | · | tweet ↗ |
| 2026-06-29 | @CrweWorld | +0.30 | Dianthus announces initiation of Phase 3 Emerge trial. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.